World's Best Scientists 2026 revealed!
Martin Zimmermann

Martin Zimmermann

D-Index & Metrics

Medicine

D-Index
83
Citations
25329
World Ranking
15608
National Ranking
822

Overview

Martin Zimmermann is affiliated with Hannover Medical School in Germany and has contributed extensively to medical research, particularly in the fields of hematology and oncology. Their work focuses on acute lymphoblastic leukemia (ALL) and lymphoma, among other related areas.

The main fields of study for Zimmermann include Medicine, with significant involvement in subfields such as Public Health, Environmental and Occupational Health, Hematology, Pathology and Forensic Medicine, Pediatrics, Perinatology and Child Health, and Oncology.

The researcher's main topics of work encompass:

  • Acute Lymphoblastic Leukemia research
  • Lymphoma Diagnosis and Treatment
  • Childhood Cancer Survivors' Quality of Life
  • Acute Myeloid Leukemia Research
  • Neutropenia and Cancer Infections
  • CAR-T cell therapy research
  • Chronic Myeloid Leukemia Treatments

Their published papers include the following notable works:

  • Childhood Acute Lymphoblastic Leukemia: Results of the Randomized Acute Lymphoblastic Leukemia Intercontinental-Berlin-Frankfurt-Münster 2009 Trial, 2023, Journal of Clinical Oncology
  • Experience with provisional WHO-entities large B-cell lymphoma with IRF4-rearrangement and Burkitt-like lymphoma with 11q aberration in paediatric patients of the NHL-BFM group, 2020, British Journal of Haematology
  • Risk factors and outcomes in children with high-risk B-cell precursor and T-cell relapsed acute lymphoblastic leukaemia: combined analysis of ALLR3 and ALL-REZ BFM 2002 clinical trials, 2021, European Journal of Cancer
  • Clinical relevance of molecular characteristics in Burkitt lymphoma differs according to age, 2022, Nature Communications
  • Whole Exome Sequencing reveals NOTCH1 mutations in anaplastic large cell lymphoma and points to Notch both as a key pathway and a potential therapeutic target, 2020, Haematologica

Zimmermann frequently publishes in the following academic venues:

  • Blood
  • Leukemia
  • Haematologica
  • Neuro-Oncology
  • Journal of Clinical Oncology

Frequent co-authors in Zimmermann's research include:

  • Martin Schrappe
  • Wilhelm Woessmann
  • Andishe Attarbaschi
  • Gunnar Cario
  • Jan Starý

Best Publications

  • Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study

    Valentino Conter;Claus R. Bartram;Maria Grazia Valsecchi;Andre Schrauder

  • Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study Group.

    Martin Schrappe;Alfred Reiter;Wolf-Dieter Ludwig;Jochen Harbott

  • Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95

    Anja Möricke;Alfred Reiter;Martin Zimmermann;Helmut Gadner

  • Coevolution of dynamical states and interactions in dynamic networks.

    Martín G. Zimmermann;Martín G. Zimmermann;Martín G. Zimmermann;Víctor M. Eguíluz;Maxi San Miguel

  • Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.

    Alfred Reiter;Martin Schrappe;Markus Tiemann;Wolf-Dieter Ludwig

  • Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study

    Martin Schrappe;Maria Grazia Valsecchi;Claus R. Bartram;André Schrauder

  • Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia.

    T Flohr;T Flohr;A Schrauder;G Cazzaniga;R Panzer-Grümayer

  • Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study.

    Brian V. Balgobind;Susana C. Raimondi;Susana C. Raimondi;Jochen Harbott;Martin Zimmermann

  • Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM group report.

    Alfred Reiter;Martin Schrappe;Wolf-Dieter Ludwig;Markus Tiemann

  • The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM Group Study NHL-BFM95

    Wilhelm Woessmann;Kathrin Seidemann;Georg Mann;Martin Zimmermann

  • Why nestedness in mutualistic networks

    Enrique Miguel Burgos;Horacio Ceva;Roberto Pedro José Perazzo;Mariano Devoto

  • Transmission of information and herd Behavior: an application to financial markets.

    Víctor M. Eguíluz;Víctor M. Eguíluz;Martín G. Zimmermann;Martín G. Zimmermann

  • Intensive Chemotherapy for Childhood Acute Lymphoblastic Leukemia: Results of the Randomized Intercontinental Trial ALL IC-BFM 2002

    Jan Stary;Martin Zimmermann;Myriam Campbell;Luis Castillo

  • Short-pulse B-non-Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.

    Kathrin Seidemann;Markus Tiemann;Martin Schrappe;Elif Yakisan

  • The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence.

    Birgit Burkhardt;Martin Zimmermann;Ilske Oschlies;Felix Niggli

  • Cooperation, social networks, and the emergence of leadership in a prisoner's dilemma with adaptive local interactions.

    Martín G. Zimmermann;Martín G. Zimmermann;Martín G. Zimmermann;Víctor M. Eguíluz

  • Secondary neoplasms subsequent to Berlin-Frankfurt-Münster therapy of acute lymphoblastic leukemia in childhood: significantly lower risk without cranial radiotherapy.

    Lutz Löning;Martin Zimmermann;Alfred Reiter;Peter Kaatsch

  • Cooperation and the Emergence of Role Differentiation in the Dynamics of Social Networks

    Víctor M. Eguíluz;Martín G. Zimmermann;Camilo J. Cela‐Conde;Maxi San Miguel

  • Thiopurine Methyltransferase (TPMT) Genotype and Early Treatment Response to Mercaptopurine in Childhood Acute Lymphoblastic Leukemia

    Martin Stanulla;Elke Schaeffeler;Thomas Flohr;Gunnar Cario

  • NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern.

    Iris H.I.M. Hollink;Marry M. van den Heuvel-Eibrink;Susan T.C.J.M. Arentsen-Peters;Marta Pratcorona

Frequent Co-Authors

Martin Schrappe
Martin Schrappe Kiel University
Martin Stanulla
Martin Stanulla Hannover Medical School
Dirk Reinhardt
Dirk Reinhardt University of Duisburg-Essen
Alfred Reiter
Alfred Reiter University of Giessen
Michael Dworzak
Michael Dworzak Medical University of Vienna
Rob Pieters
Rob Pieters Princess Máxima Center
Jochen Harbott
Jochen Harbott University of Giessen
Claus R. Bartram
Claus R. Bartram Heidelberg University
Jan Trka
Jan Trka Charles University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in Medicine doesn't always require a traditional MD path. There are several online degrees that can open doors to rewarding healthcare roles and leadership positions. For many prospective students, choosing the right program involves balancing academic goals with financial and practical considerations.

Graduate-level programs, such as an MHA, can lead to healthcare management roles. If cost is a concern, researching the cost of mha degree can help you find budget-friendly options. For nurses, advancing to the highest levels of practice is possible through affordable DNP pathways. Learn more about the most affordable dnp programs available online.

Pharmacy is another in-demand field with flexible study options. If you want to become a pharmacist, investigate your options for a pharmacy degree online. Health information management is a growing sector offering remote work and management careers. Find programs and learn about online rhit degree programs to get started in this field.

By considering these related online degrees, you'll discover flexible pathways to enter or advance in the healthcare industry, each with unique career opportunities and varying costs.

Best Scientists Citing Martin Zimmermann

Trending Scientists

Recently Published Articles